HCA Healthcare (HCA) to Release Earnings on Friday

Key Points

• Q1 2026 results: HCA will report Q1 results before the open on Friday, April 24, with analysts expecting $7.19 EPS and $19.09B in revenue, and the company guiding FY2026 EPS of 29.10–31.50.
• Recent performance and valuation: In the prior quarter HCA earned $8.01 EPS (beating estimates) on $19.51B of revenue (+6.7% YoY); the stock has a market cap of $107.9B, a PE of 17.0 and a consensus target of $537.36 (Moderate Buy).
• Dividends and insider activity: HCA raised its quarterly dividend to $0.78 ($3.12 annualized, ~0.6% yield) and insiders sold roughly 15,214 shares (~$7.8M) in the last 90 days while institutions own about 62.7% of the stock.

HCA Healthcare (NYSE:HCA - Get Free Report) will likely be issuing its Q1 2026 results before the market opens on Friday, April 24th. Analysts expect the company to announce earnings of $7.19 per share and revenue of $19.0861 billion for the quarter. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Parties may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Friday, April 24, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion for the quarter, compared to analysts' expectations of $19.67 billion. During the same period in the previous year, the business earned $6.22 earnings per share. HCA Healthcare's revenue for the quarter was up 6.7% compared to the same quarter last year. On average, analysts expect HCA Healthcare to post $25 EPS for the current fiscal year and $28 EPS for the next fiscal year.

HCA Healthcare Trading Down 1.2%

Shares of HCA Healthcare stock opened at $482.65 on Friday. The company's 50-day moving average price is $511.27 and its two-hundred day moving average price is $483.30. HCA Healthcare has a 52 week low of $314.43 and a 52 week high of $556.52. The stock has a market cap of $107.91 billion, a PE ratio of 17.01, a price-to-earnings-growth ratio of 1.50 and a beta of 1.36.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were paid a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.72. HCA Healthcare's dividend payout ratio (DPR) is 10.99%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. Robert W. Baird dropped their price target on HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating on the stock in a research note on Wednesday. Leerink Partners lifted their price target on HCA Healthcare from $507.00 to $573.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 28th. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Weiss Ratings reissued a "buy (b)" rating on shares of HCA Healthcare in a research note on Friday, March 27th. Finally, Wall Street Zen cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, February 14th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $537.36.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares of the company's stock, valued at $22,411,395. The trade was a 8.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 15,214 shares of company stock worth $7,797,595. Insiders own 1.50% of the company's stock.

Institutional Investors Weigh In On HCA Healthcare

Several large investors have recently made changes to their positions in the company. Cambient Family Office LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $232,000. T. Rowe Price Investment Management Inc. boosted its position in HCA Healthcare by 16.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,034 shares of the company's stock worth $950,000 after purchasing an additional 289 shares during the period. Compound Planning Inc. boosted its position in HCA Healthcare by 23.5% during the fourth quarter. Compound Planning Inc. now owns 1,995 shares of the company's stock worth $932,000 after purchasing an additional 380 shares during the period. Invesco Ltd. boosted its position in HCA Healthcare by 3.4% during the fourth quarter. Invesco Ltd. now owns 1,138,179 shares of the company's stock worth $531,370,000 after purchasing an additional 37,250 shares during the period. Finally, Corient Private Wealth LLC boosted its position in HCA Healthcare by 421.4% during the fourth quarter. Corient Private Wealth LLC now owns 219,276 shares of the company's stock worth $102,371,000 after purchasing an additional 177,223 shares during the period. Institutional investors own 62.73% of the company's stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.